Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.
COVID-19
Saudi Arabia
acceptance
hesitancy
questionnaire
vaccine
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
03 Oct 2021
03 Oct 2021
Historique:
pubmed:
9
7
2021
medline:
16
9
2021
entrez:
8
7
2021
Statut:
ppublish
Résumé
The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters: Demographics, medical history, knowledge and information sources about COVID-19 and vaccine, and hesitancy/acceptance of vaccinations. Bivariate analysis between several survey items and the acceptance of COVID-19 vaccine was conducted using Chi-square test. Logistic regression was used to assess to what degree each variable affects the acceptance and the hesitancy toward the COVID-19 vaccine. Approximately 64% show a desire to accept the vaccine while 18.3% were extremely hesitant to take the vaccine. Non-demographic factors that were associated with the acceptance toward the COVID-19 vaccine were the source of health information about COVID-19 (OR:1.63; 95% CI:1.07-2.47), perception toward whether the vaccine is effective on other variants of the virus (OR:7.24; 95% CI:4.58-11.45), previous uptake of the influenza vaccine (OR:1.62; 95% CI:1.07-2.47), and potential mandatory of vaccination in order to travel internationally (OR:16.52; 95% CI:10.23-26.68). This study provides an insight into factors - other than the sociodemographic - influencing the acceptance of the COVID-19 vaccine in Saudi Arabia. The government should address the COVID-19-related misinformation and rumors to increase acceptance of COVID-19 vaccination.
Identifiants
pubmed: 34236290
doi: 10.1080/21645515.2021.1936869
pmc: PMC8437496
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3338-3347Références
BMJ. 2020 Dec 11;371:m4799
pubmed: 33310748
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
J Med Ethics. 2021 Oct;47(10):709-711
pubmed: 33504627
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Nurs Health Sci. 2010 Sep 1;12(3):369-74
pubmed: 20727089
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Virus Res. 2020 Oct 15;288:198114
pubmed: 32800805
Crit Rev Diagn Imaging. 1989;29(3):307-35
pubmed: 2667567
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
J Infect Dis. 2020 Aug 4;222(5):715-718
pubmed: 32582943
BMJ. 2021 Jan 18;372:n158
pubmed: 33462092
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
PLoS One. 2021 Apr 16;16(4):e0250123
pubmed: 33861765
BMC Public Health. 2021 Jul 21;21(1):1438
pubmed: 34289817
Am J Trop Med Hyg. 2020 Aug;103(2):603-604
pubmed: 32588810
J Microbiol Immunol Infect. 2020 Jun;53(3):377-380
pubmed: 32205090
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32749458
Am J Epidemiol. 1977 May;105(5):488-95
pubmed: 871121
Vaccines (Basel). 2021 Apr 01;9(4):
pubmed: 33915890
J Med Virol. 2021 Jul;93(7):4280-4291
pubmed: 33644891
BMJ. 2020 Dec 16;371:m4857
pubmed: 33328153
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389